FLGT News and Press, Fulgent Genetics Inc. From 06/06/23

2023-06-06 07:45:00 ET If you're looking to invest $2,500 somewhere it'll grow, but you're a bit leery of buying an increasingly overpriced and hyped-up growth stock like Nvidia , Fulgent Genetics (NASDAQ: FLGT) might be up your alley. Its shares are priced for bargain hunters, ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced data from a Phase 1/1b clinical study of FID-007 in treating vari...

2023-05-23 09:53:00 ET Most biotechs don't have a diversified business model. They typically develop hardware, diagnostic tests, or drugs, as well as some of the associated platform technologies. But a few competitors, like 23andMe (NASDAQ: ME) and Fulgent Genetics (NASDAQ: FL...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that Phase 1/1b clinical data on its lead therapeutic development...

2023-05-14 01:47:50 ET Summary We initiate our coverage of Fulgent Genetics with an "outperform" rating and a $42 target price for the next 12 months. The company is continuing its Phase 1 clinical trial evaluating the efficacy of FID-007, a nano-encapsulated paclitaxel, in treati...

Total Revenue of $66.2 million Record Core Revenue of $62.7 million, growth of 150% year-over-year Raises Full Year 2023 Core Revenue Guidance to $250 million Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based compa...

2023-05-04 11:16:58 ET Major earning expected before the bell on Friday include: AMC Entertainment Holdings ( AMC ) Dominion Energy ( D ) Enbridge ( ENB ) fuboTV ( FUBO ) Warner Bros. Discovery ( WBD ) For further details see: Notable earn...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that it will release its first quarter 2023 financial results bef...

2023-04-16 14:01:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re the type that runs toward danger, these stocks to buy may be right for you. To facilitate mobility, the enterprises on this list feature a market capitalization between $500 mi...

2023-04-11 10:05:56 ET Fulgent Genetics ( NASDAQ: FLGT ) and Mission Bio are collaborating to broaden accessibility of single-cell multi-omics for drug development and clinical research. Fulgent said it is now able to offer single-cell multi-omics on the Tapestri Platform...